Coty/Rimmel Targeted With Suit Over Lash Accelerator Claims
This article was originally published in The Rose Sheet
Lawsuit seeking class-action status against Coty alleges that lengthening and multiplying claims for the firm’s Rimmel London Lash Accelerator are “false, misleading and are reasonably likely to deceive the public.”
You may also be interested in...
Marketers of cosmetic lash enhancers that haven’t abandoned prostaglandin analogs in favor of peptides or botanical extracts should take heed of a proposed class action against Rodan + Fields in California’s Northern District. Plaintiffs say they would not have purchased the firm’s Lash Boost and suffered alleged adverse effects if they’d been properly informed about product risks.
Class-action suits against beauty firms on the rise as industry pushes the envelope with claims and FDA warning letters draw attention from class-action law firms, legal experts note. Hogan Lovells attorney Mark Goodman says: “I don’t see this [trend] going away anytime soon.”
Consumer lawsuit seeking class-action certification faults the Estee Lauder Companies for scientific language in its Clinique marketing that implies FDA approval, and for performance claims that can’t be true or they’d render the product a drug. Plaintiff’s lawyer says anti-aging marketers are “pushing the envelope.”